All reports

All KCE reports are available in Dutch, French and English under several formats. Form and language of the reports

Publication year:
General domain:
Specific domain:

  1. [Economic evaluation of antiviral treatment of chronic hepatitis B in Belgium]

    KCE Reports 157 (2011)

    https://kce.fgov.be/en/publication/report/economic-evaluation-of-antiviral-treatment-of-chronic-hepatitis-b-in-belgium

  2. Antiviral agents in seasonal and pandemic influenza. Literature study and development of practice guidelines

    Please take note of the publication date of this guideline. From a methodological point of view, a guideline is generally considered obsolete after 5 years. It is therefore possible that some parts of this document are no longer relevant. KCE Reports 49 (2006)

    https://kce.fgov.be/en/publication/report/antiviral-agents-in-seasonal-and-pandemic-influenza-literature-study-and-developm

  3. Barriers and opportunities for the uptake of biosimilar medicines in Belgium

    KCE Reports 199 (2013)

    https://kce.fgov.be/en/publication/report/barriers-and-opportunities-for-the-uptake-of-biosimilar-medicines-in-belgium

  4. Cost-effectiveness of antiviral treatment of chronic hepatitis B in Belgium. Part 1: Literature review and results of a national study

    KCE Reports 127 (2010)

    https://kce.fgov.be/en/publication/report/cost-effectiveness-of-antiviral-treatment-of-chronic-hepatitis-b-in-belgium-part-

  5. Do innovative medicines against cancer always have a real added value?

    KCE Reports 343 (2021)  

    https://kce.fgov.be/en/do-innovative-medicines-against-cancer-always-have-a-real-added-value

  6. Economic evaluation of novel direct acting antiviral (DAA) treatment strategies for chronic hepatitis C

    KCE Reports 276 (2016)

    https://kce.fgov.be/en/publication/report/economic-evaluation-of-novel-direct-acting-antiviral-daa-treatment-strategies-for

  7. Future scenarios about drug development and drug pricing

    KCE Reports 271 (2016)

    https://kce.fgov.be/en/publication/report/future-scenarios-about-drug-development-and-drug-pricing

  8. Pharmaceutical and non-pharmaceutical interventions for Alzheimer’s Disease, a rapid assessment

    KCE Reports 111 (2009)

    https://kce.fgov.be/en/publication/report/pharmaceutical-and-non-pharmaceutical-interventions-for-alzheimer%E2%80%99s-disease-a-rap

  9. Publicly funded Practice-oriented Clinical Trials

    KCE Reports 246 (2015)

    https://kce.fgov.be/en/publication/report/publicly-funded-practice-oriented-clinical-trials

  10. Towards a better managed off-label use of drugs

    KCE Reports 252 (2015)

    https://kce.fgov.be/en/publication/report/towards-a-better-managed-off-label-use-of-drugs

  11. Trastuzumab in Early Stage Breast Cancer

    KCE Reports 34 (2006) 30 June (2nd edition; 22 June 2006, 1st edition)

    https://kce.fgov.be/en/publication/report/trastuzumab-in-early-stage-breast-cancer